Ashby

Quality – / 100not scored

Not scored: fewer than three checks apply, usually because no remote answered a credential-free probe or the server is a local package.

Tool list unknown · tools last changed 2026-10-19 · checked 2026-10-19 10:52 UTC

Tool changes

• 2026-10-19forgetremoved

  Delete a previously stored memory by key. Use when context is stale, the task is done, or you want to clear sensitive data the agent saved earlier. Pair with remember and recall.

• 2026-10-19pipeworx_feedbackremoved

  Tell the Pipeworx team something is broken, missing, or needs to exist. Use when a tool returns wrong/stale data (bug), when a tool you wish existed isn't in the catalog (feature/data_gap), or when something worked surprisingly well (praise). ONLY for tools served by this Pipeworx connection — if the tool came from a different MCP server in your client (another vendor's Gmail, Splunk, Slack, etc. connector), we cannot fix it and reporting it here only delays you; file it with that server instead. Not sure? Pipeworx tool names are the ones this connection lists. Describe the issue in terms of Pipeworx tools/packs — don't paste the end-user's prompt. Filing without an account returns a `claim_token`; pass it back later as pipeworx_feedback({claim_token:"pwfb_…"}) to read whether it was fixed and what changed. The team reads digests daily and signal directly affects roadmap. Rate-limited to 5 per identifier per day. Free; doesn't count against your tool-call quota.

• 2026-10-19scan_competitor_ai_presenceremoved

  Compare AI visibility across multiple entities side-by-side. Probes each entity (your brand + N competitors) with ai_visibility_check, ranks by score, surfaces which is most/least recognized. Useful for competitive AI-marketing audits: "does Claude know about us as well as our competitors?". Returns ranked list with score, confidence, signal density per entity.

• 2026-10-19release_calendar_marketsremoved

  JOIN of the official release calendar (econ data, the FOMC, FDA decisions, SEC rules) against LIVE Polymarket/Kalshi markets — which scheduled releases land in the next N hours, and which live markets resolve on them. This is a POSITIONING tool, not a speed product: results are cached like every other pack (≤ 60s TTL) and there is no push/webhook — do not use this to try to beat a release, use it to see what is coming and what is already priced. CATEGORIES: econ (CPI, Employment Situation/jobs report, GDP, PCE, PPI, retail sales, housing starts, jobless claims — via fred_release_dates per known release_id, since FRED's own cross-release calendar mostly returns recent actuals, not future dates), fed (the next FOMC meeting's rate decision, via fomc_calendar), fda (PDUFA action dates + FDA advisory-committee meetings, via pdufa_catalysts / fda_adcom_calendar), sec (SEC final rules whose own DATES clause names an effective date in the window, via federal-register recent_rules — usually finds nothing in a short window since SEC rules typically take effect 30–60 days out, which is an accurate answer, not a bug), court (ALWAYS EMPTY today — court-listener has no forward-looking scheduled-hearing calendar, only filing/termination dates, so this category returns zero releases with unsupported:true rather than fabricate one). Omit `categories` or pass "all" for every category. MATCHING AND ITS HONESTY CONTRACT: every release is returned even when it has ZERO matched markets — a release is never dropped just because nothing on Polymarket or Kalshi resolves on it (most FDA/SEC releases will show markets:[]; that is signal, not a gap). Every matched market carries resolves_on_this_release: "true" (the venue's own close/end date sits within ~36h of the release AND the question passed a subject filter — econ and fed only), "likely" (same subject filter, but the venue closes days away from the release date), or "unclear" (a keyword hit with no date to anchor against — always true for the fda category, which has no ladder structure to check a date against). matched_by names the mechanism (a Kalshi series ticker, a Polymarket search query, or an FDA keyword probe) so a caller can judge the match rather than trust a label. scheduled_at carries both `utc` and `et`; econ releases use the standing BLS/Census 8:30am ET convention (FRED's calendar itself has no clock time), FOMC decisions use the 2:00pm ET convention, and FDA/SEC dates are date_only:true (no reliable clock time exists for either). DO NOT treat a matched market as a real arbitrage or a settled fact on its own — a market question sharing tokens with a release name is not proof it settles on that release's own published number. Call resolution_audit / resolution_diff (fleet #1909) on a specific market before sizing anything here. An empty window (zero releases across every requested category) returns the SAME shape as a populated one — release_count:0, releases:[] — plus empty_reason:"no_releases_in_window" and a `hint` telling you to widen, so you never branch on the response shape and never have to guess whether zero means "nothing is scheduled" or "the lookup failed". Econ releases especially cluster on specific dates each month, so a 48h window often straddles a dead stretch.

• 2026-10-19company_register_searchremoved

  Search the NATIONAL BUSINESS REGISTERS by company name and get the register's own id back — a Companies House number, a Norwegian organisasjonsnummer, a Finnish business id, a SIREN, a Japanese corporate number, an Estonian registry code, a CNPJ, or an LEI. Use this when you want the OFFICIAL REGISTERED ENTITY and the country is not the US, or when you do not know which country it is. Registers searched: Companies House (GB), Enhetsregisteret (NO), PRH/YTJ (FI), Sirene (FR), 法人番号公表サイト (JP), RIK e-Business Register (EE), and the GLEIF LEI crosswalk, which reaches jurisdictions we have no register pack for (DE, SE, AU, SG...). THIS TOOL REFUSES TO GUESS, and that is its point: when two different companies match a name equally well it answers `match_status: "ambiguous"` with BOTH, rather than naming one. A one-word trading name usually IS ambiguous — "Bolt", "Apple", "Next", "Sea", "DNB" each match a well-known group AND unrelated micro-entities whose registered name is exactly that word — so pass `country` when you know it. Every response names EVERY register it asked under `searched[]`, with that register's own as-of date and row count, and a register that could not be reached carries an `error` there rather than reading as zero rows: "we could not ask Companies House" is never the same answer as "this company is not in Britain". `related[]` holds entities that collapsed INTO the match — the same company seen through another register, or another country's arm sharing its LEI — so a multinational returns one answer rather than tying with itself. NOT A PEOPLE SEARCH: sole traders and other natural persons are excluded on the publisher's own legal-form field, never guessed from the shape of a name. For US public companies prefer resolve_entity (CIK + ticker + FIGI); the two share this same matcher, and resolve_entity returns these register fields too.

• 2026-10-19entity_profileremoved

  "Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when `value` was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (the latest ANNUAL Revenues, NetIncomeLoss, Cash, diluted EPS, capex and operating cash flow, each with its period_end, SEC form and the accession of the filing it came from — plus EntityCommonStockSharesOutstanding, which is the newest COVER-PAGE share count the filer has published rather than an annual one, so its period_end is a cover date after the quarter closed and it is the right per-share denominator; a filer tagging a fallback concept appears under the name of that tag instead, e.g. PaymentsToAcquireProductiveAssets instead of PaymentsToAcquirePropertyPlantAndEquipment); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. `sources_used` / `sources_failed` say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. `sources_skipped` is the third state: a leg we deliberately did NOT run, each entry carrying a `reason` token and a plain-English `detail` (the Purple Book is skipped for a filer SEC classifies outside the life-science SIC bands, since it lists only 351(a)/(k) biologics licence holders). Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit `notes` line, not a bare failure. `type` accepts "company" or "ticker" interchangeably — both take the same `value` shapes above.

• 2026-10-19compare_entitiesremoved

  "Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

• 2026-10-19deep_researchremoved

  ACCOUNT REQUIRED (free — sign in via GitHub at https://pipeworx.io/signup; depth:"thorough" needs a paid plan). If you are not signed in, use ask_pipeworx instead — it works on every tier. Grounded multi-source research across Pipeworx's 1834 STRUCTURED data sources (SEC filings, FRED/BLS economics, FDA, USPTO patents, markets, science, government records, etc.) in ONE call — this is NOT open-web search. Decomposes your question into focused facets, routes each to the right one of 6,985 tools IN PARALLEL, and returns a findings packet: verbatim evidence + confidence + source + fetched_at + a stable pipeworx:// citation per finding, with explicit gaps[] for facets the data couldn't answer (never invented). Best for broad/multi-part questions over structured data ("compare X and Y's regulatory + financial exposure", "research the filings + market picture for ACME"). For a single lookup use ask_pipeworx (one LLM call, not many). For BREAKING or colloquial CURRENT-NEWS / "what's the world saying about X" topics, prefer ask_pipeworx — it routes to live news APIs and the *-news-feeds packs; deep_research returns mostly empty gaps[] when the topic isn't in the structured catalog. Second-hop iteration: depth:"standard" re-angles unanswered gaps (gap recovery); depth:"thorough" additionally chases the best leads from the first pass — so multi-step questions resolve in one call. Every finding carries a `hop` field and a citation_uri — a resolvable pipeworx:// record URI, present only when the source emits one that resources/read can actually serve, so a citation you get back is always fetchable. "standard" and "thorough" also return contradictions[] flagging findings that disagree. Large records are semantically excerpted to the passages relevant to each facet (not head-truncated), so answers deep in a long filing/series aren't missed. Expect 15-60s (thorough with its follow-up + contradiction pass: up to ~90s).

• 2026-10-19ashby_get_jobremoved

  Get full job posting by ID. Returns description, requirements, hiring stage, and applicant count.

• 2026-10-19company_factsremoved

  TYPED, DETERMINISTIC financial facts for a US public company for an EXPLICITLY NAMED reporting period — "Apple revenue for fiscal 2023", "Walmart net income FY2026 Q3", "Microsoft cash at the end of fiscal 2024". PREFER OVER entity_profile / get_company_financials whenever the period matters: those answer "the most recent figures" and will happily hand back FY2025 when you asked about FY2019, and neither separates a discrete quarter from a year-to-date figure. This one refuses instead — it NEVER substitutes the latest period for the period requested, NEVER returns 0 for missing data, NEVER lets a 9-month YTD number answer a quarterly question, and NEVER converts a currency. Every answer carries the exact us-gaap concept it came from, what that concept MEASURES (NetIncomeLoss excludes non-controlling interests, ProfitLoss includes them — not synonyms), the accession number and a link to the filing on sec.gov, the restatement trail of any superseded figures, and a contract + derivation version to pin against. Fiscal periods are the FILER'S OWN, anchored on their fiscal-year end, so Walmart's year ending 2026-01-31 is FY2026 and Apple's ending 2025-09-27 is FY2025. Attributes: revenue, net_income, cash, gross_profit, operating_income, eps_diluted, capex, operating_cash_flow, long_term_debt, shares_outstanding (the dei COVER-PAGE share count, so its period end is the cover date, after the quarter closed — that is the most current count the filing carries). Units are not all USD: shares_outstanding is in `shares` with currency null, eps_diluted in `USD/shares`. A discrete quarter the filer never filed — every Q4, and Q2/Q3 of cash-flow lines, which are filed year-to-date — is DERIVED as YTD(q) minus YTD(q-1) and comes back with `reported: false`, the subtraction named in `derivation` (fy_minus_9m / ytd_9m_minus_6m / ytd_6m_minus_3m) and both legs with their filings in `derived_from`; test `reported` if you will only accept a figure lifted from a filing. Per-share and balance-sheet figures are NEVER derived. Every non-answer is a named status — `unavailable` (the filer did not report it for that period; the periods that DO exist are listed, without values), `unsupported` (outside what v1 covers — a non-us-gaap filer, an unknown attribute, a non-USD unit), `ambiguous` (the company name matched two filers equally well; both are named), `conflicting` (two filings the same day disagree; both are returned and neither is picked), `partial` (a value with no accession behind it). Source: SEC EDGAR, XBRL financial facts, one publisher read once — see `corroboration`. Same response is served at POST https://gateway.pipeworx.io/v1/facts for non-MCP callers.

Showing the latest 10. Full history: list_changes · trend: quality JSON.

Checks run on what our credential-free, read-only probes observe; tools are never called and no code audit is performed. How it is computed.